{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:50:36Z","timestamp":1791978636937,"version":"4.4.0"},"reference-count":155,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Chem."],"DOI":"10.3389\/fchem.2018.00122","type":"journal-article","created":{"date-parts":[[2018,4,17]],"date-time":"2018-04-17T04:14:31Z","timestamp":1523938471000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["The Physiopathological Role of the Exchangers Belonging to the SLC37 Family"],"prefix":"10.3389","volume":"6","author":[{"given":"Anna Rita","family":"Cappello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosita","family":"Curcio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Lappano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Maggiolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Dolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,17]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/j.febslet.2015.05.018","article-title":"Identification of glucose-6-phosphate transporter as a key regulator functioning at the autophagy initiation step","volume":"589","author":"Ahn","year":"2015","journal-title":"FEBS Lett."},{"key":"B2","doi-asserted-by":"publisher","first-page":"9289","DOI":"10.1021\/bi049334h","article-title":"Homology modeling of the human microsomal glucose 6-phosphate transporter explains the mutations that cause the glycogen storage disease type Ib","volume":"43","author":"Almqvist","year":"2004","journal-title":"Biochemistry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.ymgme.2005.12.011","article-title":"Glycogen storage disease type Ib without neutropenia generated by a novel splice-site mutation in the glucose-6-phosphate translocase gene","volume":"88","author":"Angaroni","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1086\/301727","article-title":"The gene for glycogen storage disease type 1b maps to chromosome 11q23","volume":"62","author":"Annabi","year":"1998","journal-title":"Am. J. Hum. Genet"},{"key":"B5","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1006\/abbi.1996.9874","article-title":"Chlorogenic acid and hydroxynitrobenzaldehyde: new inhibitors of hepatic glucose 6-phosphatase","volume":"339","author":"Arion","year":"1997","journal-title":"Arch. Biochem. Biophys."},{"key":"B6","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1006\/abbi.1997.0563","article-title":"Chlorogenic acid analogue S 3483: a potent competitive inhibitor of the hepatic and renal glucose-6-phosphatase systems","volume":"351","author":"Arion","year":"1998","journal-title":"Arch. Biochem. Biophys."},{"key":"B7","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/S0021-9258(19)45462-8","article-title":"The specificity of glucose 6-phosphatase of intact liver microsomes","volume":"247","author":"Arion","year":"1972","journal-title":"J. Biol. Chem."},{"key":"B8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/BF01732001","article-title":"On the involvement of a glucose 6-phosphate transport system in the function of microsomal glucose 6-phosphatase","volume":"6","author":"Arion","year":"1975","journal-title":"Mol. Cell. Biochem"},{"key":"B9","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.2337\/diabetes.50.11.2591","article-title":"Acute inhibition of glucose-6-phosphate translocator activity leads to increased de novo lipogenesis and development of hepatic steatosis without affecting VLDL production in rats","volume":"50","author":"Bandsma","year":"2001","journal-title":"Diabetes"},{"key":"B10","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.bbcan.2005.05.001","article-title":"Negative and positive regulation of HIF-1: a complex network","volume":"1755","author":"B\u00e1rdos","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"B11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.cellsig.2015.11.010","article-title":"The G protein estrogen receptor (GPER) is regulated by endothelin-1 mediated signaling in cancer cells","volume":"28","author":"Bartella","year":"2016","journal-title":"Cell. Signal."},{"key":"B12","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s00424-003-1105-0","article-title":"The human sugar-phosphate\/phosphate exchanger family SLC37","volume":"447","author":"Bartoloni","year":"2004","journal-title":"Pflugers Arch."},{"key":"B13","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1006\/geno.2000.6395","article-title":"Cloning and characterization of a putative human glycerol 3-phosphate permease gene (SLC37A1 or G3PP) on 21q22.3: mutation analysis in two candidate phenotypes, DFNB10 and a glycerol kinase deficiency","volume":"70","author":"Bartoloni","year":"2000","journal-title":"Genomics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF00441175","article-title":"Glyeogenosis type I b complicated by severe granuloeytopenia resembling inherited Neutropenia","volume":"137","author":"Bartram","year":"1981","journal-title":"Eur. J. Pediatr."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1128\/MCB.00166-09","article-title":"Hypoxia-induced autophagy is mediated through hypoxia-inducible factor induction of BNIP3 and BNIP3L via their BH3 domains","volume":"29","author":"Bellot","year":"2009","journal-title":"Mol. Cell. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/83713","article-title":"The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3","volume":"27","author":"Bennett","year":"2001","journal-title":"Nat. Genet."},{"key":"B17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13059-014-0569-x","article-title":"An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss","volume":"16","author":"Benton","year":"2015","journal-title":"Genome Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s10545-007-0479-0","article-title":"A novel starch for the treatment of glycogen storage diseases","volume":"30","author":"Bhattacharya","year":"2007","journal-title":"J. Inherit. Metab. Dis"},{"key":"B19","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/1750-1172-9-47","article-title":"Liver transplantation in glycogen storage disease type I","volume":"9","author":"Boers","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa0805051","article-title":"A syndrome with congenital neutropenia and mutations in G6PC3","volume":"360","author":"Boztug","year":"2009","journal-title":"N. Engl. J. Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1084\/jem.20151159","article-title":"T cell metabolism drives immunity","volume":"212","author":"Buck","year":"2015","journal-title":"J. Exp. Med"},{"key":"B22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/BF01799362","article-title":"Diagnosis of a novel glycogen storage disease: type 1aSP","volume":"13","author":"Burchell","year":"1990","journal-title":"J. Inherit. Metab. Dis"},{"key":"B23","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1042\/bj2300489","article-title":"Stabilization of glucose-6-phosphatase activity by a 21000-dalton hepatic microsomal protein","volume":"230","author":"Burchell","year":"1985","journal-title":"Biochem. J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"619","DOI":"10.2174\/1389557515666150709110222","article-title":"Bergamot (Citrus bergamia Risso) flavonoids and their potential benefits in human hyperlipidemia and atherosclerosis: an overview","volume":"16","author":"Cappello","year":"2016","journal-title":"Mini Rev. Med. Chem."},{"key":"B25","doi-asserted-by":"publisher","first-page":"34280","DOI":"10.1074\/jbc.M006439200","article-title":"Structural requirements for the stability and microsomal transport activity of the human glucose-6-phosphate transporter","volume":"275","author":"Chen","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B26","doi-asserted-by":"publisher","first-page":"3199","DOI":"10.1093\/hmg\/11.25.3199","article-title":"Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib","volume":"11","author":"Chen","year":"2002","journal-title":"Hum. Mol. Genet"},{"key":"B27","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1093\/hmg\/ddg263","article-title":"Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter","volume":"12","author":"Chen","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B28","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1096\/fj.07-104851","article-title":"The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic","volume":"22","author":"Chen","year":"2008","journal-title":"FASEB J."},{"key":"B29","first-page":"1521","article-title":"Glycogen storage diseases","volume-title":"The Metabolic and Molecular Bases of Inherited Disease, 8th Edn","author":"Chen","year":"2001"},{"key":"B30","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1056\/NEJM198401193100306","article-title":"Cornstarch therapy in type I glycogen-storage disease","volume":"310","author":"Chen","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1172\/JCI30443","article-title":"Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta","volume":"117","author":"Cheung","year":"2007","journal-title":"J. Clin. Invest."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1517\/14712598.2011.578067","article-title":"Recombinant AAV-directed gene therapy for type I glycogen storage diseases","volume":"11","author":"Chou","year":"2011","journal-title":"Expert Opin. Biol. Ther"},{"key":"B33","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/B978-0-12-800223-0.00010-4","article-title":"The SLC37 family of sugar-phosphate\/phosphate exchangers","volume":"73","author":"Chou","year":"2014","journal-title":"Curr. Top. Membr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/MOH.0b013e328331df85","article-title":"Neutropenia in type Ib glycogen storage disease","volume":"17","author":"Chou","year":"","journal-title":"Curr. Opin. Hematol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nrendo.2010.189","article-title":"Glycogen storage disease type I and G6Pase-b deficiency: etiology and therapy","volume":"6","author":"Chou","year":"","journal-title":"Nat. Rev. Endocrinol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.mam.2012.05.010","article-title":"The SLC37 family of phosphate-linked sugar phosphate antiporters","volume":"34","author":"Chou","year":"2013","journal-title":"Mol. Aspects Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s10545-014-9772-x","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase\/glucose-6-phosphate transporter complexes","volume":"38","author":"Chou","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2174\/1566524024605798","article-title":"Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex","volume":"2","author":"Chou","year":"2002","journal-title":"Curr. Mol. Med."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3945\/ajcn.2008.26352","article-title":"Use of modified cornstarch therapy to extend fasting in glycogen storage disease types Ia and Ib","volume":"88","author":"Correia","year":"2008","journal-title":"Am. J. Clin. Nutr"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1016\/j.bbapap.2016.07.009","article-title":"New insights about the structural rearrangements required for substrate translocation in the bovine mitochondrial oxoglutarate carrier","volume":"1864","author":"Curcio","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1038\/ni.3269","article-title":"Glycolysis controls the induction of human regulatory T cells by modulating the expression of FOXP3 exon 2 splicing variants","volume":"16","author":"De Rosa","year":"2015","journal-title":"Nat. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1365-2567.2005.02317.x","article-title":"Imbalance of regulatory T cells in human autoimmune diseases","volume":"117","author":"Dejaco","year":"2006","journal-title":"Immunology"},{"key":"B43","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1080\/09687860500269335","article-title":"Substrate-induced conformational changes of the mitochondrial oxoglutarate carrier: a spectroscopic and molecular modelling study","volume":"22","author":"Della Rocca","year":"2015","journal-title":"Mol. Membr. Biol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1007\/BF02680002","article-title":"Association of glycogen storage disease 1b and Crohn disease: results of a North American survey","volume":"161","author":"Dieckgraefe","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"B45","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1874467211104030167","article-title":"Glycerophospholipid synthesis as a novel drug target against cancer","volume":"4","author":"Dolce","year":"2011","journal-title":"Curr. Mol. Pharmacol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"e65550","DOI":"10.1371\/journal.pone.0065550","article-title":"Detection of haplotypes associated with prenatal death in dairy cattle and identification of deleterious mutations in GART, SHBG and SLC37A2","volume":"8","author":"Fritz","year":"2013","journal-title":"PLoS ONE"},{"key":"B47","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-5793(99)01248-X","article-title":"Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c","volume":"459","author":"Galli","year":"1999","journal-title":"FEBS Lett."},{"key":"B48","doi-asserted-by":"publisher","first-page":"12297","DOI":"10.1074\/jbc.M900573200","article-title":"ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy","volume":"284","author":"Ganley","year":"2009","journal-title":"J. Biol. Chem"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.2337\/diabetes.50.7.1531","article-title":"Novel arguments in favor of the substrate-transport model of glucose-6-phosphatase","volume":"50","author":"Gerin","year":"2001","journal-title":"Diabetes"},{"key":"B50","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S0014-5793(97)01463-4","article-title":"Sequence of a putative glucose-6-phosphate translocase, mutated in glycogen storage disease type 1b","volume":"419","author":"Gerin","year":"1997","journal-title":"FEBS Lett"},{"key":"B51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0378-1119(98)00614-3","article-title":"Structure of the gene mutated in glycogen storage disease type Ib","volume":"227","author":"Gerin","year":"1999","journal-title":"Gene"},{"key":"B52","doi-asserted-by":"publisher","first-page":"12479","DOI":"10.1074\/jbc.M313271200","article-title":"Histidine 167 is the phosphate acceptor in glucose-6-phosphatase-beta forming a phosphohistidine enzyme intermediate during catalysis","volume":"279","author":"Ghosh","year":"2004","journal-title":"J. Biol. Chem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"32837","DOI":"10.1074\/jbc.M201853200","article-title":"The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis","volume":"277","author":"Ghosh","year":"2002","journal-title":"J. Biol. Chem."},{"key":"B54","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/0002-8223(93)92246-T","article-title":"Nutrition therapy for hepatic glycogen storage diseases","volume":"93","author":"Goldberg","year":"1993","journal-title":"J. Am. Diet. Assoc."},{"key":"B55","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1056\/NEJM197602192940805","article-title":"Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease","volume":"294","author":"Greene","year":"1976","journal-title":"N. Engl. J. Med."},{"key":"B56","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/BJ20101225","article-title":"Carbohydrate response-element-binding protein (ChREBP) and not the liver X receptor \u03b1 (LXR\u03b1) mediates elevated hepatic lipogenic gene expression in a mouse model of glycogen storage disease type 1","volume":"432","author":"Grefhorst","year":"2010","journal-title":"Biochem. J"},{"key":"B57","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.cmet.2005.05.009","article-title":"Calmodulin-dependent protein kinase kinase beta is an alternative upstream kinase for AMP-activated protein kinase","volume":"2","author":"Hawley","year":"2005","journal-title":"Cell Metab."},{"key":"B58","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1479-7364-3-2-195","article-title":"Analysis and update of the human solute carrier (SLC) gene superfamily","volume":"3","author":"He","year":"2009","journal-title":"Hum. Genomics"},{"key":"B59","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1021\/jm9607360","article-title":"Chlorogenic acid and synthetic chlorogenic acid derivatives: novel inhibitors of hepatic glucose-6-phosphate translocase","volume":"40","author":"Hemmerle","year":"1997","journal-title":"J. Med. Chem"},{"key":"B60","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0014-2999(99)00748-7","article-title":"Alterations of carbohydrate and lipid intermediary metabolism during inhibition of glucose-6-phosphatase in rats","volume":"386","author":"Herling","year":"1999","journal-title":"Eur. J. Pharmacol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1089\/104454901316976073","article-title":"Glucocorticoids activate transcription of the gene for glucose-6-phosphate transporter, deficient in glycogen storage disease type 1b","volume":"20","author":"Hiraiwa","year":"2001","journal-title":"DNA Cell Biol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5532","DOI":"10.1074\/jbc.274.9.5532","article-title":"Inactivation of the glucose-6-phosphate transporter causes glycogen storage disease type 1b","volume":"274","author":"Hiraiwa","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1007\/s10545-015-9864-2","article-title":"Alternative nighttime nutrition regimens in glycogen storage disease type I: a controlled crossover study","volume":"38","author":"Hochuli","year":"2015","journal-title":"J. Inherit. Metab. Dis"},{"key":"B64","first-page":"166","article-title":"TMbase\u2014A database of membrane spanning protein segments","volume":"347","author":"Hoffman","year":"1993","journal-title":"Biol. Chem."},{"key":"B65","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/cmdc.201600629","article-title":"Old drug scaffold, new activity: Thalidomide-correlated compounds exert different effects on breast cancer cell growth and progression","volume":"12","author":"Iacopetta","year":"2017","journal-title":"Chem. Med. Chem."},{"key":"B66","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1007\/s10549-009-0620-x","article-title":"SLC37A1 gene expression is up-regulated by epidermal growth factor in breast cancer cells","volume":"122","author":"Iacopetta","year":"2010","journal-title":"Breast Cancer Res. Treat"},{"key":"B67","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1023\/A:1005677912539","article-title":"Quantitative analysis of glucose-6-phosphate translocase gene expression in various human tissues and haematopoietic progenitor cells","volume":"23","author":"Ihara","year":"2000","journal-title":"J. Inherit. Metab. Dis."},{"key":"B68","doi-asserted-by":"publisher","first-page":"2754","DOI":"10.1128\/jb.174.9.2754-2762.1992","article-title":"Structure and function of the uhp genes for the sugar phosphate transport system in Escherichia coli and Salmonella typhimurium","volume":"174","author":"Island","year":"1992","journal-title":"J. Bacteriol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s004390000371","article-title":"Mutation analysis in glycogen storage disease type 1 non-a","volume":"107","author":"Janecke","year":"2000","journal-title":"Hum. Genet"},{"key":"B70","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/cr.2013.161","article-title":"Autophagy and human diseases","volume":"24","author":"Jiang","year":"2014","journal-title":"Cell Res"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1182\/blood-2009-12-258491","article-title":"Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome","volume":"116","author":"Jun","year":"2010","journal-title":"Blood"},{"key":"B72","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1182\/blood-2010-08-302059","article-title":"G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis","volume":"117","author":"Jun","year":"2011","journal-title":"Blood"},{"key":"B73","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.1182\/blood-2013-05-502435","article-title":"Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib","volume":"123","author":"Jun","year":"2014","journal-title":"Blood"},{"key":"B74","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1091\/mbc.E08-12-1249","article-title":"ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery","volume":"20","author":"Jung","year":"2009","journal-title":"Mol. Biol. Cell"},{"key":"B75","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.3892\/ol.2017.7559","article-title":"Upregulated solute carrier family 37 member 1 in colorectal cancer is associated with poor patient outcome and metastasis","volume":"15","author":"Kikuchi","year":"2018","journal-title":"Oncol. Lett."},{"key":"B76","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1172\/JCI114684","article-title":"Impaired metabolic function and signaling defects in phagocytic cells in glycogen storage disease type 1b","volume":"86","author":"Kilpatrick","year":"1990","journal-title":"J. Clin. Invest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"E110","DOI":"10.1152\/ajpendo.00404.2006","article-title":"The major facilitator superfamily member Slc37a2 is a novel macrophage-specific gene selectively expressed in obese white adipose tissue","volume":"293","author":"Kim","year":"2007","journal-title":"Am. J. Physiol. Endoc. M"},{"key":"B78","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/ncb2152","article-title":"AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1","volume":"13","author":"Kim","year":"2011","journal-title":"Nat. Cell Biol"},{"key":"B79","doi-asserted-by":"publisher","first-page":"5704","DOI":"10.1182\/blood-2007-12-129114","article-title":"Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib","volume":"111","author":"Kim","year":"2008","journal-title":"Blood"},{"key":"B80","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/S0092-8674(04)00335-6","article-title":"Homeostatic expansion of T cells during immune insufficiency generates autoimmunity","volume":"117","author":"King","year":"2004","journal-title":"Cell"},{"key":"B81","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1038\/gim.2014.128","article-title":"Diagnosis and management of glycogen storage disease type I: a practice guideline of the American College of Medical Genetics and Genomics","volume":"16","author":"Kishnani","year":"2014","journal-title":"Genet. Med."},{"key":"B82","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-017-0462-7","article-title":"Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs","volume":"10","author":"Knutson","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"B83","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.tem.2009.02.003","article-title":"Emerging therapies for glycogen storage disease type I","volume":"20","author":"Koeberl","year":"2009","journal-title":"Trends Endocrinol. Metab"},{"key":"B84","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.cdd.4401984","article-title":"ER stress (PERK\/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation","volume":"14","author":"Kouroku","year":"2007","journal-title":"Cell Death Differ."},{"key":"B85","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2009.05.005","article-title":"Activation of a HIF1\u03b1-PPARgamma axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy","volume":"9","author":"Krishnan","year":"2009","journal-title":"Cell Metab."},{"key":"B86","doi-asserted-by":"publisher","first-page":"5021","DOI":"10.1182\/blood-2002-10-3128","article-title":"Apoptotic neutrophils in the circulation of patients with glycogen storage disease type 1b (GSD1b)","volume":"101","author":"Kuijpers","year":"2003","journal-title":"Blood"},{"key":"B87","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1067\/mpd.2000.107472","article-title":"Glycogen storage disease type Ib without neutropenia","volume":"137","author":"Kure","year":"2000","journal-title":"J. Pediatr."},{"key":"B88","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.33549\/physiolres.933439","article-title":"The role of PPARgamma in cardiovascular diseases","volume":"65","author":"Kvandova","year":"2016","journal-title":"Physiol. Res"},{"key":"B89","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.1093\/hmg\/ddx325","article-title":"Liver-directed gene therapy for murine glycogen storage disease type Ib","volume":"26","author":"Kwon","year":"2017","journal-title":"Hum. Mol. Genet"},{"key":"B90","doi-asserted-by":"publisher","first-page":"S53","DOI":"10.1007\/BF02679995","article-title":"Glycogen storage disease type I: indications for liver and\/or kidney transplantation","volume":"161","author":"Labrune","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"B91","doi-asserted-by":"publisher","first-page":"17063","DOI":"10.1038\/cddiscovery.2017.63","article-title":"The lauric acid-activated signaling prompts apoptosis in cancer cells","volume":"3","author":"Lappano","year":"2017","journal-title":"Cell Death Discov"},{"key":"B92","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1093\/hmg\/ddr445","article-title":"IRE1 plays an essential role in ER stress-mediated aggregation of mutant huntingtin via the inhibition of autophagy flux","volume":"21","author":"Lee","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"B93","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1002\/hep.25717","article-title":"Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy","volume":"56","author":"Lee","year":"2012","journal-title":"Hepatology"},{"key":"B94","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ng0696-203","article-title":"Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type 1a mouse","volume":"13","author":"Lei","year":"1996","journal-title":"Nat. Genet."},{"key":"B95","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1172\/JCI117645","article-title":"Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c","volume":"95","author":"Lei","year":"1995","journal-title":"J. Clin. Invest."},{"key":"B96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.intimp.2017.01.020","article-title":"Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib","volume":"44","author":"Letkemann","year":"2017","journal-title":"Int. Immunopharmacol"},{"key":"B97","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1182\/blood-2002-08-2576","article-title":"Inhibition of microsomal glucose-6-phosphate transport in human neutrophils results in apoptosis: a potential explanation for neutrophil dysfunction in glycogen storage disease type 1b","volume":"101","author":"Leuzzi","year":"2003","journal-title":"Blood"},{"key":"B98","doi-asserted-by":"publisher","first-page":"31656","DOI":"10.1074\/jbc.273.48.31656","article-title":"Cloning and characterization of cDNAs encoding a candidate glycogen storage disease type 1b protein in rodents","volume":"273","author":"Lin","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B99","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s004390000404","article-title":"Human variant glucose-6-phosphate transporter is active in microsomal transport","volume":"107","author":"Lin","year":"2000","journal-title":"Hum. Genet"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1128\/jb.172.4.1688-1693.1990","article-title":"Topology of the Escherichia coli UhpT sugar-phosphate transporter analyzed by using TnphoA fusions","volume":"172","author":"Lloyd","year":"1990","journal-title":"J. Bacteriol."},{"key":"B101","first-page":"1130","volume-title":"Escherichia coli Salmonella: Cellular Molecular Biology","author":"Maloney","year":"1996"},{"key":"B102","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0014-5793(98)01129-6","article-title":"Structure and mutation analysis of the glycogen storage disease type 1b gene","volume":"436","author":"Marcolongo","year":"1998","journal-title":"FEBS Lett"},{"key":"B103","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s10545-006-0146-x","article-title":"A patient with common glycogen storage disease type Ib mutations without neutropenia or neutrophil dysfunction","volume":"29","author":"Martens","year":"2006","journal-title":"J. Inherit. Metab. Dis"},{"key":"B104","doi-asserted-by":"publisher","first-page":"S10","DOI":"10.1007\/s00431-002-0998-5","article-title":"Glycogen storage disease type I: diagnosis and phenotype\/genotype correlation","volume":"161","author":"Matern","year":"2002","journal-title":"Eur. J. Pediatr"},{"key":"B105","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1203\/00006450-199309000-00005","article-title":"Interferon-gamma corrects the respiratory burst defect in vitro in monocyte-derived macrophages from glycogen storage disease type 1b patients","volume":"34","author":"McCawley","year":"1993","journal-title":"Pediatr. Res"},{"key":"B106","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1182\/blood-2010-01-265942","article-title":"Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis","volume":"116","author":"McDermott","year":"2010","journal-title":"Blood"},{"key":"B107","doi-asserted-by":"publisher","first-page":"453","DOI":"10.4049\/jimmunol.1002213","article-title":"Hypoxia selectively inhibits respiratory burst activity and killing of Staphylococcus aureus in human neutrophils","volume":"186","author":"McGovern","year":"2011","journal-title":"J. Immunol"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.4049\/jimmunol.1500861","article-title":"G-CSF and GM-CSF in Neutropenia","volume":"195","author":"Mehta","year":"2015","journal-title":"J. Immunol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"S227","DOI":"10.1007\/s10545-008-0810-4","article-title":"Myasthenia gravis in a patient affected by glycogen storage disease type Ib: a further manifestation of an increased risk for autoimmune disorders?","volume":"31","author":"Melis","year":"2008","journal-title":"J. Inherit. Metab. Dis"},{"key":"B110","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.4049\/jimmunol.1601946","article-title":"Cutting edge: increased autoimmunity risk in glycogen storage disease type 1b is associated with a reduced engagement of glycolysis in T Cells and an impaired regulatory T cell function","volume":"198","author":"Melis","year":"2017","journal-title":"J. Immunol."},{"key":"B111","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00431-005-1657-4","article-title":"Genotype\/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature","volume":"164","author":"Melis","year":"2005","journal-title":"Eur. J. Pediatr"},{"key":"B112","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1111\/j.1651-2227.2003.tb00825.x","article-title":"Crohn's-like ileo-colitis in patients affected by glycogen storage disease Ib: two years_ follow-up of patients with a wide spectrum of gastrointestinal signs","volume":"92","author":"Melis","year":"2003","journal-title":"Acta Paediatr."},{"key":"B113","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jpeds.2006.11.056","article-title":"Increased prevalance of thyroid autoimmunity and hypothyroidism in patients with glycogen storage disease type 1","volume":"150","author":"Melis","year":"2007","journal-title":"J. Pediatr."},{"key":"B114","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.humimm.2016.06.016","article-title":"Lymphopenia and autoimmunity: a double-edged sword","volume":"77","author":"Merayo-Chalico","year":"2016","journal-title":"Hum. Immunol"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/ncb2329","article-title":"The AMPK signalling pathway coordinates cell growth, autophagy and metabolism","volume":"13","author":"Mihaylova","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1097\/00001665-200501000-00010","article-title":"Unusual oral manifestations and evolution in glycogen storage disease type Ib","volume":"16","author":"Mortellaro","year":"2005","journal-title":"J. Craniofac. Surg."},{"key":"B117","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/ncb2708","article-title":"MTOR inhibits autophagy by controlling ULK1 ubiquitylation, self-association and function through AMBRA1 and TRAF6","volume":"15","author":"Nazio","year":"2013","journal-title":"Nat. Cell Biol"},{"key":"B118","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.1016\/S0021-9258(17)44560-1","article-title":"Type 1c, a novel glycogenosis","volume":"258","author":"Nordlie","year":"1983","journal-title":"J. Biol. Chem"},{"key":"B119","doi-asserted-by":"publisher","first-page":"e23157","DOI":"10.1371\/journal.pone.0023157","article-title":"SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters","volume":"6","author":"Pan","year":"2011","journal-title":"PLoS ONE"},{"key":"B120","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.ymgme.2008.10.005","article-title":"Structure-function study of glucose-6-phosphate transporter, an eukaryotic antiporter deficient in glycogen storage disease type Ib","volume":"96","author":"Pan","year":"2009","journal-title":"Mol. Genet. Metab."},{"key":"B121","doi-asserted-by":"publisher","first-page":"6144","DOI":"10.1074\/jbc.273.11.6144","article-title":"Transmembrane topology of glucose-6-phosphatase","volume":"273","author":"Pan","year":"1998","journal-title":"J. Biol. Chem."},{"key":"B122","doi-asserted-by":"publisher","first-page":"13865","DOI":"10.1074\/jbc.274.20.13865","article-title":"Transmembrane topology of human glucose-6-phosphate transporter","volume":"274","author":"Pan","year":"1999","journal-title":"J. Biol. Chem."},{"key":"B123","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","article-title":"Major facilitator superfamily","volume":"62","author":"Pao","year":"1998","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B124","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.tips.2016.11.008","article-title":"Classification systems of secondary active transporters","volume":"38","author":"Perland","year":"2017","journal-title":"Trends Pharmacol. Sci"},{"key":"B125","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1146\/annurev.ph.54.030192.004403","article-title":"Mammalian facilitative glucose transporter family: structure and molecular regulation","volume":"54","author":"Pessin","year":"1992","journal-title":"Annu. Rev. Physiol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.jpeds.2007.09.031","article-title":"Bone marrow transplantation in glycogen storage disease type 1b","volume":"152","author":"Pierre","year":"2008","journal-title":"J. Pediatr."},{"key":"B127","doi-asserted-by":"publisher","first-page":"e68740","DOI":"10.1371\/journal.pone.0068740","article-title":"Whole genome SNP genotyping and exome sequencing reveal novel genetic variants and putative causative genes in congenital hyperinsulinism","volume":"8","author":"Proverbio","year":"2013","journal-title":"PLoS ONE"},{"key":"B128","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1007\/BF02679990","article-title":"Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSDI)","volume":"161","author":"Rake","year":"2002","journal-title":"Eur. J. Pediatr"},{"key":"B129","doi-asserted-by":"publisher","first-page":"4250","DOI":"10.1182\/blood-2007-12-128967","article-title":"Sepsis-induced inhibition of neutrophil chemotaxis is mediated by activation of peroxisome proliferator-activated receptor-{gamma}","volume":"112","author":"Reddy","year":"2008","journal-title":"Blood"},{"key":"B130","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jhep.2009.05.026","article-title":"Liver transplantation for glycogen storage disease type Ia","volume":"51","author":"Reddy","year":"2009","journal-title":"J. Hepatol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"e0160013","DOI":"10.1371\/journal.pone.0160013","article-title":"Validation of deleterious mutations in vorderwald cattle","volume":"11","author":"Reinartz","year":"2016","journal-title":"PLoS ONE"},{"key":"B132","doi-asserted-by":"publisher","first-page":"261","DOI":"10.3343\/alm.2017.37.3.261","article-title":"Novel SLC37A4 mutations in korean patients with glycogen storage disease Ib","volume":"37","author":"Rihwa","year":"2017","journal-title":"Ann. Lab. Med."},{"key":"B133","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3389\/fimmu.2016.00216","article-title":"Regulatory T-Cell-mediated suppression of conventional T-Cells and dendritic cells by different cAMP intracellular pathways","volume":"7","author":"Rueda","year":"2016","journal-title":"Front. Immunol."},{"key":"B134","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.jsbmb.2014.11.012","article-title":"Dissecting high from lowresponders in a vitamin D3 intervention study","volume":"148","author":"Saksa","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol"},{"key":"B135","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.cell.2010.02.024","article-title":"Regulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids","volume":"141","author":"Sancak","year":"2010","journal-title":"Cell"},{"key":"B136","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1111\/jhn.12030","article-title":"Effect of dietary interventions in the maintenance of normoglycaemia in glycogen storage disease type 1a: a systematic review and meta-analysis","volume":"26","author":"Shah","year":"2013","journal-title":"J. Hum. Nutr. Diet."},{"key":"B137","doi-asserted-by":"crossref","first-page":"A243","DOI":"10.1096\/fasebj.21.5.A243-b","article-title":"The variant glucose-6-phosphate transporter decreases protein stability and requires MyoD-dependent alternative splicing during myogenesis of muscle cells","volume":"21","author":"Shieh","year":"2007","journal-title":"FASEB J."},{"key":"B138","doi-asserted-by":"publisher","first-page":"47098","DOI":"10.1074\/jbc.M309472200","article-title":"Glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia","volume":"278","author":"Shieh","year":"2003","journal-title":"J. Biol. Chem"},{"key":"B139","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1001\/archinte.1986.00360140200029","article-title":"The role of raw starches in the treatment of type I glycogenosis","volume":"146","author":"Sidbury","year":"1986","journal-title":"Arch. Intern. Med"},{"key":"B140","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0167-4781(00)00133-0","article-title":"Identification of cAMP analogue inducible genes in RAW264 macrophages","volume":"1492","author":"Takahashi","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"B141","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1007\/s004310051279","article-title":"How many forms of glycogen storage disease type I?","volume":"159","author":"Veiga-da-Cunha","year":"2000","journal-title":"Eur. J. Pediatr"},{"key":"B142","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1086\/302068","article-title":"A gene on chromosome 11q23 coding for a putative glucose-6-phosphate translocase is mutated in glycogenstorage disease types Ib and Ic","volume":"63","author":"Veiga-da-Cunha","year":"1998","journal-title":"Am. J. Hum. Genet"},{"key":"B143","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/sj.ejhg.5200366","article-title":"The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a","volume":"7","author":"Veiga-da-Cunha","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"key":"B144","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1067\/mpd.2000.105232","article-title":"Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen storage disease type I","volume":"137","author":"Visser","year":"2000","journal-title":"J. Pediatr"},{"key":"B145","doi-asserted-by":"publisher","first-page":"S83","DOI":"10.1007\/BF02680001","article-title":"Granulocyte colony-stimulating factor in glycogen storage disease type 1b. results of the European Study on Glycogen Storage Disease Type 1","volume":"161","author":"Visser","year":"2002","journal-title":"Eur. J. Pediatr."},{"key":"B146","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1007\/BF02679991","article-title":"Effect of continuous glucose therapywith uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease","volume":"161","author":"Weinstein","year":"2002","journal-title":"Eur. J. Pediatr"},{"key":"B147","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.jnutbio.2014.04.002","article-title":"Primary vitamin D receptor target genes as biomarkers for the vitamin D3 status in the hematopoietic system","volume":"25","author":"Wilfinger","year":"2014","journal-title":"J. Nutr. Biochem."},{"key":"B148","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1093\/ajcn\/65.5.1507","article-title":"Cornstarch regimens for nocturnal treatment of young adults with type I glycogen storage disease","volume":"65","author":"Wolfsdorf","year":"1997","journal-title":"Am. J. Clin. Nutr"},{"key":"B149","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1023\/A:1021831621210","article-title":"Glycogen storage diseases","volume":"4","author":"Wolfsdorf","year":"2003","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"B150","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/mt.2010.64","article-title":"Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy","volume":"18","author":"Yiu","year":"2010","journal-title":"Mol. Ther."},{"key":"B151","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/sj.gt.3302869","article-title":"Glucose-6-phosphate transporter gene therapy corrects metabolic and myeloid abnormalities in glycogen storage disease type Ib mice","volume":"14","author":"Yiu","year":"2007","journal-title":"Gene Ther."},{"key":"B152","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.jhep.2008.11.026","article-title":"Normoglycemia alone is insufficient to prevent long term complications of hepatocellular adenoma in glycogen storage disease type Ib mice","volume":"51","author":"Yiu","year":"2009","journal-title":"J. Hepatol."},{"key":"B153","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1242\/jcs.03172","article-title":"Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes","volume":"119","author":"Young","year":"2006","journal-title":"J. Cell Sci"},{"key":"B154","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1074\/jbc.275.2.828","article-title":"Correction of glycogen storage disease type 1a in a mouse model by gene therapy","volume":"275","author":"Zingone","year":"2000","journal-title":"J. Biol. Chem."},{"key":"B155","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/nrm3025","article-title":"MTOR: from growth signal integration to cancer, diabetes and ageing","volume":"12","author":"Zoncu","year":"2011","journal-title":"Nat. Rev. Mol. Cell Biol."}],"container-title":["Frontiers in Chemistry"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fchem.2018.00122\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,19]],"date-time":"2022-08-19T22:04:59Z","timestamp":1660946699000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fchem.2018.00122\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,17]]},"references-count":155,"alternative-id":["10.3389\/fchem.2018.00122"],"URL":"https:\/\/doi.org\/10.3389\/fchem.2018.00122","relation":{},"ISSN":["2296-2646"],"issn-type":[{"value":"2296-2646","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,17]]},"article-number":"122"}}